Callan Capital, LLC Astrazeneca PLC Transaction History
Callan Capital, LLC
- $1.42 Billion
- Q3 2024
A detailed history of Callan Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Callan Capital, LLC holds 10,927 shares of AZN stock, worth $732,218. This represents 0.06% of its overall portfolio holdings.
Number of Shares
10,927
Previous 10,358
5.49%
Holding current value
$732,218
Previous $807,000
5.45%
% of portfolio
0.06%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.21 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.81 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...